GIPICA

Welcome to the Brand page for “GIPICA”, which is offered here for Pharmaceutical preparations for the treatment of cancer cells; cells for medical or clinical use; pharmaceutical preparations for activating cellular function; biological preparations for the treatment of immune system related disorders; biological preparations for the treatment of cancer; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for tumor treatment; vaccines; pharmaceutical preparations for the treatment of cancers with t cells; pharmaceutical preparations for the treatment of cancers with car-t cells;product development in the field of cell therapy; biomedical research services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; product development, biologics development; biological research and analysis; consultancy in the field of analysis of biology sequence processing for medical research purposes; multiple nucleotide sequence analysis for scientific research purposes; dna sequence analysis for scientific research purposes; medical research services in the field of cell separation; medical research in the field of biologics;.

Its status is currently believed to be active. Its class is unavailable. “GIPICA” is believed to be currently owned by “Eutilex Co., Ltd.”